Research progress of asprosin in metabolic diseases and cardiovascular diseases / 中国医师杂志
Journal of Chinese Physician
;
(12): 1744-1747, 2022.
Article
in Chinese
| WPRIM
| ID: wpr-956363
ABSTRACT
Asprosin is a newly discovered fasting-induced glucogenic adipokine, which is involved in regulating appetite, glucose and fat metabolism and oxidative stress. Recently, it has been found that asprosin is related to metabolic diseases such as type 2 diabetes, obesity, nonalcoholic fatty liver, polycystic ovary syndrome, and cardiovascular diseases such as coronary heart disease and dilated cardiomyopathy, and plays an active role in heart protection. In this paper, the related research progress is summarized.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Journal of Chinese Physician
Year:
2022
Type:
Article
Similar
MEDLINE
...
LILACS
LIS